HEARING AID EFFECTIVENESS ON PATIENTS WITH CHRONIC TINNITUS AND ASSOCIATED HEARING LOSS: SYSTEMATICS REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v9i5.1704Keywords:
Chronic tinnitus, Frequency, Hearing aid, Hearing lossAbstract
Tinnitus, the perception of sound in the absence of an obvious external source, is even more frequent, affecting around ten percent of adults in the United States. Tinnitus is defined as the sense of sound in the absence of an obvious external source. Tinnitus is typically accompanied by hearing loss, but this is not always the case. It is conceivable for it to occur either by itself or in conjunction with a loss of hearing of any type. Tinnitus and hearing loss are both caused by a wide variety of conditions, the most frequent of which is age-related hearing loss. Other, less common causes include malignancies of the brain and skull base. Hearing loss can be broken down into three basic categories: sensorineural, conductive, or mixed (where both conductive and sensorineural components are present). The perception of sound in the absence of external acoustic stimulation for an extended length of time (more than three months) is the hallmark of chronic tinnitus. Tinnitus is quite common, with an estimated incidence of 10–15% in the adult population; however, prevalence estimates can vary widely from study to study. Tinnitus is characterized by a buzzing or ringing sound in the ear. A minority of people may experience severe psychological distress as a direct result of the situation, despite the fact that the majority of people are able to adapt to the perception and report very mild emotional distress as a result of it. Tinnitus Questionnaire (abbreviated as TQ), Tinnitus Handicap Inventory (abbreviated as THI), and Tinnitus Functional Index (abbreviated as TFI) are the three self-report questionnaires that are used the most frequently for quantifying tinnitusrelated suffering. The total scores of these measures properly capture both the suffering associated with tinnitus and the change that is attributable to treatments. In patients who have tinnitus and chronic hearing loss, the use of hearing aids is successful in suppressing the symptoms; however, the usage of the device must be carried out for at least six months in order for the treatment to take effect.
References
Shapiro SB, Noij KS, Naples JG, Samy RN. Hearing Loss and Tinnitus. Med Clin North Am. 2021 Sep;105(5):799– 811.
Henry JA, Reavis KM, Griest SE, Thielman EJ, Theodoroff SM, Grush LD, et al. Tinnitus: an epidemiologic perspective. Otolaryngol Clin North Am. 2020;53(4):481–99.
Stohler NA, Reinau D, Jick SS, Bodmer D, Meier CR. A study on the epidemiology of tinnitus in the United Kingdom. Clin Epidemiol. 2019;855–71.
Oosterloo BC, Croll PH, Baatenburg de Jong RJ, Ikram MK, Goedegebure A. Prevalence of tinnitus in an aging population and its relation to age and hearing loss. Otolaryngol Neck Surg. 2021;164(4):859–68.
Ciorba A, Bianchini C, Pastore A, Mazzoli M. Pathogenesis of tinnitus: any role for oxidative stress? J Int Adv Otol. 2013;9(2):249.
Manche SK, Madhavi J, Meganadh KR, Jyothy A. Association of tinnitus and hearing loss in otological disorders: a decade-long epidemiological study in a South Indian population. Braz J Otorhinolaryngol. 2016;82:643–9.
Jafari Z, Kolb BE, Mohajerani MH. Age-related hearing loss and tinnitus, dementia risk, and auditory amplification outcomes. Ageing Res Rev. 2019;56:100963.
Bauer CA. Tinnitus. N Engl J Med. 2018;378(13):1224–31.
Löhler J, Cebulla M, Shehata-Dieler W, Volkenstein S, Völter C, Walther LE. Hearing Impairment in Old Age. Dtsch Arztebl Int. 2019 Apr;116(17):301–10.
Radunz CL, Okuyama CE, Branco-Barreiro FCA, Pereira RMS, Diniz SN. Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Braz J Otorhinolaryngol. 2020;86(6):734–42.
Gates GA, Mills JH. Presbycusis. Lancet (London, England). 2005 Sep;366(9491):1111–20.
Simonetti P, Vasconcelos LG, Gândara MR, Lezirovitz K, Medeiros ÍRT de, Oiticica J. Hearing aid effectiveness on patients with chronic tinnitus and associated hearing loss. Braz J Otorhinolaryngol. 2022;88 Suppl 3(Suppl 3):S164– 70.
Simonetti P, Ono CR, de Godoi Carneiro C, Khan RA, Shahsavarani S, Husain FT, et al. Evaluating the efficacy of hearing aids for tinnitus therapy–A Positron emission tomography study. Brain Res. 2022;1775:147728.
Boecking B, Rausch L, Psatha S, Nyamaa A, Dettling-Papargyris J, Funk C, et al. Hearing Therapy Improves Tinnitus-Related Distress in Mildly Distressed Patients with Chronic Tinnitus and Mild-to-Moderate Hearing Loss: A Randomized-Controlled Cross-Over Design. Vol. 11, Journal of Clinical Medicine. 2022.
Boecking B, Brueggemann P, Kleinjung T, Mazurek B. All for one and one for all?–examining convergent validity and responsiveness of the German versions of the Tinnitus Questionnaire (TQ), Tinnitus Handicap Inventory (THI), and Tinnitus Functional Index (TFI). Front Psychol. 2021;12:596037.
Hoare DJ, Edmondson-Jones M, Sereda M, Akeroyd MA, Hall D. Amplification with hearing aids for patients with tinnitus and co-existing hearing loss. Cochrane database Syst Rev. 2014 Jan;(1):CD010151.
Sereda M, Xia J, El Refaie A, Hall DA, Hoare DJ. Sound therapy (using amplification devices and/or sound generators) for tinnitus. Cochrane database Syst Rev. 2018 Dec;12(12):CD013094.
Chou R, Dana T, Bougatsos C, Fleming C, Beil T. No Title. Rockville (MD); 2011.
Wang J, Puel J-L. Presbycusis: An Update on Cochlear Mechanisms and Therapies. J Clin Med. 2020 Jan;9(1).
Valentinuzzi ME. Hearing Aid history: from ear trumpets to digital technology. IEEE Pulse. 2020;11(5):33–6.
Almufarrij I, Dillon H, Munro KJ. Does probe-tube verification of real-Ear hearing Aid amplification characteristics improve outcomes in adults? A systematic review and meta-analysis. Trends Hear. 2021;25:2331216521999563.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
